TREVOR LIPPINCOTT: Open Payments
NPI 1861178410 · SALEM, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,111 in 225 payments from 20 companies in 2025. Trend: 2023 $199 · 2024 $2,264 · 2025 $4,111
Food & beverage: $3,926Education: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $596 |
| Janssen Biotech, Inc. | 18 | $446 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $344 |
| Incyte Corporation | 21 | $329 |
| Lilly USA, LLC | 16 | $311 |
| Galderma Laboratories, L.P. | 17 | $272 |
| PFIZER INC. | 13 | $231 |
| UCB, Inc. | 8 | $230 |
| E.R. Squibb & Sons, L.L.C. | 14 | $230 |
| Amgen Inc. | 14 | $196 |
Products named: TREMFYA, OPZELURA, RINVOQ, SKYRIZI, TALTZ, CIBINQO, Bimzelx, Sotyktu.
Industry payments across NH — which companies pay providers there.
